Lv12
30 积分 2025-01-07 加入
HER2-Low Breast Cancer: Pathological and Clinical Landscape
4小时前
待确认
An Overview of Clinical Development of Agents for Metastatic or Advanced Breast Cancer Without ERBB2 Amplification (HER2-Low)
4小时前
已完结
Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials
4小时前
已完结
PARP Inhibitors for Breast Cancer Treatment
1天前
已完结
皖公网安备34019202002308
